McKenna Long & Aldridge LLP, JP Morgan, London Biotechnology Network and PharmaVentures cordially invite you to join us for a dialogue focusing on U.S. government funding and U.K. industry collaboration opportunities in the biotechnology sector and the emerging greentech/industrial biotechnology arenas.
Location:
Imperial College
London Lecture Theatre 342
South Kensington Campus
London SW7 2AZ
13:30 - 14:15
Welcome and Keynote Address
Gerald R. Kovacs, Ph.D.
Acting Director of Project BioShield
U.S. Department of Health and Human Services
Assistant Secretary for Preparedness & Response
Biomedical Advanced Research and Development Authority
14:15 - 15:15
Panel 1: U.S. Funding and Collaboration Opportunities: Success Stories and Lessons Learned
Moderator: John Clerici, McKenna Long & Aldridge LLP
Panelists:
Randy Mills, Osiris Therapeutics
George Painter, Ph.D., Chimerix Inc.
Barbara Domayne-Hayman, Stabilitech
15:15 - 15:30
Break
15:30 - 16:30
Panel 2: Current Trends in Life Sciences Financing in the U.S. and U.K. Including Cross Border Issues
Moderator: Mick Cochran, McKenna Long & Aldridge LLP Panelists:
Dr. Tibor Papp, PharmaVentures
Fraser Campbell, Grant Thornton UK
Stephen Potter, Genzyme Corporation
16:30 - 17:30
Panel 3: Potential Areas of U.S. Biotech Investment in Related Areas (Industrial Biotechnology/Greentech)
Moderator: Dr. Jennifer Hannesschlager, McKenna Long & Aldridge LLP
Panelists:
Tony Jones, London Biotechnology Network
Dr. Kent Lohman, Midwest Research Institute
Dr. Fintan Walton, CEO of PharmaVentures
17:30 - 18:30
Cocktail Reception